WESLEY FISCHMAN: Open Payments
NPI 1811404676 · SPRING VALLEY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 49 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,195
Food & beverage: $1,095Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $372 |
| Novartis Pharmaceuticals Corporation | 9 | $172 |
| Regeneron Healthcare Solutions, Inc. | 2 | $119 |
| GENZYME CORPORATION | 3 | $91 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $90 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| PFIZER INC. | 3 | $48 |
| Cycle Pharmaceuticals Inc | 2 | $43 |
| Ionis Pharmaceuticals, Inc. | 1 | $27 |
Products named: FASENRA, DUPIXENT, NEFFY, Rhapsido, XOLAIR, AIRSUPRA, TRELEGY ELLIPTA, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
